CL
BTAL icon

Choreo LLC’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Choreo LLC’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,668
Closed -$442K – 472
2023
Q1 		$442K Buy
+21,668
New +$436K 0.02% 318

Other funds holding BTAL

TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
APA
Astoria Portfolio Advisors New York $470M AUM 21.04% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $605M AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

Choreo LLC's BTAL Position: Q2 2023 in Review

Choreo LLC sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 21,668 shares — an estimated $442K sold.

Choreo LLC first reported a position in BTAL in Q1 2023 and held it in 1 quarter. The position peaked at $442K in Q1 2023. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Choreo LLC reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Choreo LLC sold 21,668 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $442K.
  • Choreo LLC first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 1 quarter.
  • Choreo LLC's AGF US Market Neutral Anti-Beta Fund position peaked at $442K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Choreo LLC's 13F filing for Q2 2023, filed 4 Aug 2023.